The novel interactors CACNA1I and CACNA1G targeted by nervous system drugs are calcium channels that are known to be associated with Alzheimer’s disease and schizophrenia, respectively93,94. This evidence concerns the gene CACNA1I and early-onset autosomal dominant Alzheimer disease.